About Us | Alkem Laboratories Ltd. was founded in 1974 by one of India's respected entrepreneurs, Shri Samprada Singh. In the last three and a half decades of its operations, Alkem has successfully emerged as a leading domestic Pharma major in and is rapidly multiplying its international footprint. | | | Alkem has carved out for itself, a special reputation in the field of sales and marketing. In India, the strength of Alkem's sales and marketing, along with its expertise in brand buildings are recognized widely and are considered as amongst the very best. Some of the biggest brands in the Indian Pharma market are the Alkem brands. The Alkem product portfolio encompasses a wide spectrum of therapeutic groups, ranging from Anti bacterials, NSAIDS, Gastro Enterology products, Gynaecology products, CNS and CVS products along with an impressive oncology range. Alkem has shown remarkable success with new products and converted several of them into market leaders. For a company with patented new molecules, seeking sales and marketing partners in India, Alkem emerges as the ideal Indian partner. | |
|
 | Fact Sheet | | | Year of Establishment | : | 1974 | | Legal Status of Firm | : | Partnership | | Nature of Business | : | Manufacturer, Trader | | Number of Employees | : | more than 1000 People | | Turnover | : | More than US$ 100 Million (or > Rs. 400 Crore Approx.) | | Major Markets | : | Australia/NZ, Indian Subcontinent, East Europe, East Asia, Middle East and South East Asia | | Trade Membership | : | Business development
Keenly exploring options of Strategic Partnerships, acquisitions & JV''s in select markets.
Tie-up for drug development and contract manufacturing.
Alkem has successfully inlicenced several patented molecules from international companies vis Oxum (Oculus Innovative Science, USA), Cytobrush (Cooper Surgical, USA), Pycnogenol (Hor Phag, Switzerland) etc. Many more inlicencing deals are at advanced stages of discussion, encompassing several therapeutic groups. |
|
|
QualityBy investing in world class manufacturing facilities, approved by World regulatory authorities including US FDA, UK MHRA, ANVISA BRAZIL, MCC South Africa and TGA Australia, Alkem currently exports to 35 countries including the regulated markets of EU, CIS and South East Asia.
InfrastructureAlkem has several manufacturing facilities, primarily situated in Daman & Taloja. The Taloja facility was the Alkem first manufacturing facility. Bulk of Alkem''s production is undertaken in the "State of the Art" manufacturing facilities in Daman. Alkem also has a general manufacturing facility wherein cardiovascular products, anti-diabetics, NSAIDS, neuro-psychiatry products etc. are manufactured. The modern Betalactam facility is responsible for Alkem''s entire Betalactam range.
Amaliya Manfacturing Facility- I
It comprises two production blocks (General and Cephalosporins), warehouse, quality assurance cum administrative block, utilities block and an effluent treatment plant. These production blocks are designed to meet the domestic and export production requirements. The General block is a three-floor structure having production on ground and first floors measuring 3025.35 sq. mtrs. and 1596.94 sa. mtrs. respectively. A part of the first floor and the third floor house the HVAC system etc.
The Cephalosporin block is a three-floor structure having production on ground and first floors measuring 877.85 sq.mtrs. and 877.85 sq.mtrs. respectively. The third floor houses the HVAC system etc. The ware housing facility has available area measuring1893.04 sq. mtrs. on ground floor and 1893.04 sq. mtrs. on first
Amaliya B-Lactam Facility - I
It comprises one production block (for-Lactams) having warehousing, quality assurance, administrative office and a separate utilities block. This plant is designed to meet the domestic and export production requirements. This plant is a four storeyed structure having production on ground and second floors measuring 1996 sq.mtrs. and 2072 sq.mtrs. respectively. A part of the first floor and the third floor house the HVAC, water system etc. The injection facility of this plant is a modular clean room based design and this is one of the best and most modern manufacturing facilities in the country.
The ware housing facility has the available area measuring 504 sq.mtrs on ground floor and 428 sq.mtrs. on second floor.
Kachigam Unit
The Kachigam unit is four storeyed structure with available area of 2275 sq.mtrs. and 2450 sq. mtrs. for the ground and the second floor respectively with the first and the fourth floors mainly housing the HVAC etc. The ware housing facility has an available area of 875 sq. mtrs. This GMP unit is designed for production of injections, tablets, capsules and dry syrups for domestic and export markets.
The major equipments installed in this unit are three high-speed dry powder injection and two high-speed dry syrup filling and packing lines as well as tablets and hard gelatin capsules production and packing lines. The unit has an independent, well-equipped quality, assurance department
The new plant at Baddi was commissioned in the year 2005. It is situated in clean, green & scenic surrounding. The production at Baddi caters to both domestic & International business. The plant has been designed for Cephalosporins & General categories products. Tablets, Capsules, Dry Powder Injectables & Oral Suspensions are he dosage forms that can be manufactured in this facility.
The salient features of the plant are
It is a cluster of Isolated blocks.
Built up Area - 220000 Sq. Feet.
Cephalosporins Block - 70000 Sq. Feet.
General Block - 100000 Sq. Feet.
QA / QC - 10000Sq. Feet.
All plant openings are cordoned off by air curtains, PVC curtains & insectecutors.
Well equipped workshop for regular plant maintenance
Dedicated water recirculation loops in all the 3 blocks.
Contact Details| | Company Name:
| Alkem Laboratories Limited | | Contact Person: | Mr. Manoj Kapoor | | Telephone: | +(91)-(22)-39829999
| | Address: | Devashish, Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra - 400013 (India) |
|
|
Processing...
